No Detail Found!

Computational Investigation of Ciprofloxacin-Related Compounds as Potential Therapeutic Inhibitors in Mycobacterium tuberculosis

Author(s)
Mahwish Akhtar Department of Pharmaceutical Chemistry, Faculty of Pharmaceutical Sciences, Dow College of Pharmacy, Dow University of Health Sciences, Pakistan
Zuhaib Ahmed Department of Pharmaceutical Chemistry, Faculty of Pharmaceutical Sciences, Dow College of Pharmacy, Dow University of Health Sciences, Pakistan
Sabahat Abdullah Department of Pharmaceutical Chemistry, Faculty of Pharmacy and Pharmaceutical Sciences, University of Karachi, Pakistan
Umbreen Farrukh Department of Pharmacognosy, Faculty of Pharmaceutical Sciences, Dow College of Pharmacy, Dow University of Health Sciences, Pakistan
Saima Mahmood Malhi Department of Pharmacology, Faculty of Pharmaceutical Sciences, Dow College of Pharmacy, Dow University of Health Sciences, Pakistan
Shumaila Tasneem Department of Pharmacology, Faculty of Pharmaceutical Sciences, Dow College of Pharmacy, Dow University of Health Sciences, Pakistan
Abstract
Aim and Objectives: The goal of the current study is to employ in-silico methods to identify anti-tubercular drugs. Background: Mycobacterium tuberculosis (Mtb), an acid-fast bacillus, is the causative agent of tuberculosis (TB). It is a deadly infectious disease that mainly affects the lungs but can spread to nearly any tissue or organ in the body. Although TB is usually chronic, lasting months or even years, it can also exhibit acute forms that, if untreated, can be fatal in a matter of weeks or days. Material and Methods: Ciprofloxacin (CFX), an antibiotic from the fluoroquinolone class, was selected based on literature review. A library of compounds with at least 40% structural similarity to CFX was retrieved from the ZINC database. Molecular docking was performed using AutoDock-Vina to evaluate the binding affinity (?G) of the 32 selected compounds, and the results were compared to CFX as a reference. The top 10 compounds with the lowest binding energies were further analyzed for drug-likeness and physicochemical properties using SwissADME, pkCSM tools and ADMETlab 2.0. Results: The study's findings revealed that all analogs had ?G values higher than that of CFX, with SD25 exhibiting the most notable ?G value at -18.4 kcal/mol. Additionally, the selected analogs met all pharmacokinetic, toxicological, physicochemical, and drug-likeness criteria, suggesting their potential as effective therapeutic candidates. Conclusion: All of the chosen analogs showed the ability to bind and inhibit DNA gyrase, according to the in-silico investigation. According to the results, SD25 exhibits significant potential as a lead molecule and needs more research to be developed as a medication for the treatment of tuberculosis.
Publication Details
Page(s) 123-138
DOI DOI not available
Published Journal: RADS Journal of Pharmacy and Allied Health Sciences, Volume: 3, Issue: 2, Year: 2025

Request the full text from PASTIC

Keywords
DNA Gyrase, Tuberculosis, Ciprofloxacin, molecular docking, In-Silico Study
References
Palittapongarnpim P,Tantivitayakul P,Aiewsakun P,Mahasirimongkol S,Jaemsai B .2024 .Genomic Interactions Between Mycobacterium tuberculosis and Humans. Annual Review of Genomics and Human Genetics, 25 : .
Organization WH .2024 .Consolidated guidance on tuberculosis data generation and use. Module 1. , : .
Naeem A,Badshah SL,Muska M,Ahmad N,Khan K. .2016 .The current case of quinolones: synthetic approaches and antibacterial activity. Molecules, 21(4) : 268.
Singh S,Kaur G,Mangla V,Gupta MK .2015 .Quinoline and quinolones: promising scaffolds for future antimycobacterial agents. Journal of enzyme inhibition and medicinal chemistry, 30(3) : 492-504.
Fan Y-L,Wu J,Cheng X-W,Z X-W .2018 .Feng L-S. Fluoroquinolone derivatives and their anti-tubercular activities. European journal of medicinal chemistry, 146 : 554-63.
Organization WH .2019 .WHO consolidated guidelines on drug-resistant tuberculosis treatment. , : .
Castro RA,Ross A,Kamwela L,Reinhard M,Loiseau C,Feldmann J .2020 .The genetic background modulates the evolution of fluoroquinolone-resistance in Mycobacterium tuberculosis. Molecular biology and evolution, 37(1) : 195-207.
Kanji A,Hasan R .2019 .Efflux pump as alternate mechanism for drug resistance in Mycobacterium tuberculosis. Indian Journal of Tuberculosis, 66(1) : 20-5.
Rossolini GM,Arena F,Pecile P,Pollini S. .2014 .Update on the antibiotic resistance crisis. Current opinion in pharmacology., 18 : 56-60.
Wallis RS,Maeurer M,Mwaba P,Chakaya J,Rustomjee R,Migliori GB .2016 .Tuberculosis-advances in development of new drugs, treatment regimens, host-directed therapies, and biomarkers. The Lancet infectious diseases, 16(4) : e34-e46.
Hoagland DT,Liu J,Lee RB,Lee RE .2016 .New agents for the treatment of drug-resistant Mycobacterium tuberculosis. Advanced drug delivery reviews, 102 : 55-72.
Tiberi S,Du Plessis N,Walzl G,Vjecha MJ,Rao M,Ntoumi F .2018 .Tuberculosis: progress and advances in development of new drugs, treatment regimens, and host-directed therapies. The Lancet Infectious Diseases, 18(7) : e183-e98.
Qin X,Jiang B,Song H,Du N,Zhang Y,Zhong X .2023 .Design, synthesis and anti-TB and anti-bacterial activity of Ciprofloxacin derivatives containing N-(amino) piperazine moieties. Medicinal Chemistry Research, 32(3) : 556-70.
Szulczyk D,Woziński M,Koliński M,Kmiecik S,Głogowska A,Augustynowicz-Kopeć E .2023 .Menthol-and thymol-based ciprofloxacin derivatives against Mycobacterium tuberculosis: In vitro activity, lipophilicity, and computational studies. Scientific Reports, 13(1) : 16328.
Skepper CK,Armstrong D,Balibar CJ,Bauer D,Bellamacina C,Benton BM .2020 .Topoisomerase inhibitors addressing fluoroquinolone resistance in Gram-negative bacteria. Journal of Medicinal Chemistry, 63(14) : 7773-816.
Fallica AN,Barbaraci C,Amata E,Pasquinucci L,Turnaturi R,Dichiara M .2021 .Nitric oxide photo-donor hybrids of ciprofloxacin and norfloxacin: a shift in activity from antimicrobial to anticancer agents. Journal of Medicinal Chemistry, 64(15) : 11597-613.
Halder SK,Elma F. .2021 .In silico identification of novel chemical compounds with antituberculosis activity for the inhibition of InhA and EthR proteins from Mycobacterium tuberculosis. J Clin Tuberc Other Mycobact Dis, 24 : 100246.
Sonnenkalb L,Carter JJ,Spitaleri A,Iqbal Z,Hunt M,Malone KM .2023 .Bedaquiline and clofazimine resistance in Mycobacterium tuberculosis: an in-vitro and in-silico data analysis. Lancet Microbe, 4(5) : e358-e68.
Krisnamurti GC .2021 .Capsaicinoids from Capsicum annuum as an Alternative FabH Inhibitor of Mycobacterium Tuberculosis: In Silico Study. Makara Journal of Science, 25(4) : .
Valencia J,Rubio V,Puerto G,Vasquez L,Bernal A,Mora JR .2022 .Biological Evaluation of Novel Quinolinone-Based Thiosemicarbazones against Mycobacterium tuberculosis. Antibiotics, 12(1) : 61.
Coba-Males MA,Santamaría-Aguirre J,Alcívar-León CD .2021 .In Silico Evaluation of New Fluoroquinolones as Possible Inhibitors of Bacterial Gyrases in Resistant Gram-Negative Pathogens. , 43 : .
Coba-Males MA,Lavecchia MJ,Alcivar-Leon CD,Santamaria-Aguirre J. Novel CD .2023 .Fluoroquinolones with Possible Antibacterial Activity in Gram-Negative Resistant Pathogens: In Silico Drug Discovery. Molecules, 28(19) : .
Mahwish Akhtar AI,Sabahat Abdullah,Imran Mohammad .2025 .Computational Studies on Analogues of 8-Methoxy Derivatives of Fluoroquinolones as Potential Inhibitors of Mycobacterium Tuberculosis. RADS J Pharm Allied Health Sci, 3(1) : 25-49.
Benselama W,Benchouk W. .2024 .In silico design based on quantum chemical, molecular docking studies and ADMET predictions of ciprofloxacin derivatives as novel potential antibacterial and antimycrobacterium agents. J Biomol Struct Dyn, 42(15) : 7650-66.
Szulczyk D,Wozinski M,Kolinski M,Kmiecik S,Glogowska A,Augustynowicz-Kopec E .2023 .Menthol- and thymol-based ciprofloxacin derivatives against Mycobacterium tuberculosis: in vitro activity, lipophilicity, and computational studies. Sci Rep, 13(1) : 16328.
Studio BD .2020 .. , : .
Blower TR,Williamson BH,Kerns RJ,Berger JM .2016 .Crystal structure and stability of gyrasefluoroquinolone cleaved complexes from Mycobacterium tuberculosis. Proceedings of the National Academy of Sciences, 113(7) : 1706-13.
Daina A,Michielin O,Zoete V. .2017 .SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Scientific reports, 7(1) : 42717.
Pires DE,Blundell TL,Ascher DB .2015 .pkCSM: predicting small-molecule pharmacokinetic and toxicity properties using graph-based signatures. Journal of medicinal chemistry, 58(9) : 4066-72.
Xiong G,Wu Z,Yi J,Fu L,Yang Z,Hsieh C .2021 .0: an integrated online platform for accurate and comprehensive predictions of ADMET properties. Nucleic acids research, 49(W1) : W5-W14.
Veber DF,Johnson SR,Cheng H,Smith BR,Ward KW,Kopple KD .2002 .Molecular properties that influence the oral bioavailability of drug candidates. Journal of medicinal chemistry, 45(12) : 2615-23.
Lipinski CA,Lombardo F,Dominy BW,Feeney PJ .1997 .Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Advanced drug delivery reviews, 23(1-3) : 3-25.
Ghose AK,Viswanadhan VN,Wendoloski JJ .1999 .A knowledge-based approach in designing combinatorial or medicinal chemistry libraries for drug discovery. 1. A qualitative and quantitative characterization of known drug databases. Journal of combinatorial chemistry, 1(1) : 55-68.
Egan WJ,Merz KM,Baldwin JJ KM .2000 .Prediction of drug absorption using multivariate statistics. Journal of medicinal chemistry, 43(21) : 3867-77.
Muegge I,Heald SL,Brittelli D. .2001 .Simple selection criteria for drug-like chemical matter. Journal of medicinal chemistry, 44(12) : 1841-6.
Paixão P,Gouveia LF,Morais JA LF .2009 .Prediction of drug distribution within blood. european journal of pharmaceutical sciences, 36(4-5) : 544-54.
Norinder U,Haeberlein M. .2002 .Computational approaches to the prediction of the bloodbrain distribution. Advanced drug delivery reviews, 54(3) : 291-313.
Rendic S,Guengerich FP .2015 .Survey of human oxidoreductases and cytochrome P450 enzymes involved in the metabolism of xenobiotic and natural chemicals. , 28(1) : 38-42.
0

Citations

0

Downloads

11

Views